Stock MATN MATEON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Mateon Therapeutics, Inc. OTC Markets

Equities

MATN

US57667K1097

End-of-day quote OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Mateon Therapeutics, Inc. -.--% -.--%
05-15 Oncotelic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-12 Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Mateon Therapeutics, Inc.

869461af60f5186f510e29c750.mYwoi5o_jz-DfRU42kGnmKw9n6iISGDySKmwC0nkCvg.ocIYuvRd4FLsL3IVnBXerMFfr8y-fxaAf8DARyCjWoLV-Uzn_FrkXPM1Zg~936c433715b471f1bb10242aaf880d30

Upcoming events on Mateon Therapeutics, Inc.

14/08/2024 Q2 2024 Earnings Release (Projected)
17/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Mateon Therapeutics, Inc.

07/05/2024 Biopharma Nexus Conference
28/11/2023 Ibero American Chatbot and Conversational AI Summit
15/11/2023 14:00 Q3 2023 Earnings Release
17/08/2023 Q2 2023 Earnings Release
04/06/2023 BIO International Convention
17/04/2023 12:00 Q4 2022 Earnings Release
21/11/2022 14:00 Q3 2022 Earnings Release
19/11/2022 00:30 Society for Neuro Oncology Meeting - Abstract No DDEL 16
19/11/2022 00:30 Society for Neuro Oncology Meeting - Abstract No RTID 04
10/11/2022 13:00 Society for Immunotherapy of Cancer Meeting - Abstract No 599
28/08/2022 Biotechgate Digital Partnering Conference
22/08/2022 14:00 Interim 2022 Earnings Release
07/07/2022 JCA-AACR Special Joint Conference
12/06/2022 BIO International Convention
15/05/2022 Q1 2022 Earnings Release (Projected)
18/04/2022 12:00 FY 2021 Earnings Release
07/04/2022 American Association of Cancer Research Meeting - Abstract No-2937
27/03/2022 MedInvest Pharmaceutical and Biotechnology Investor Conference
24/01/2022 TGF-? for Immuno-Oncology Drug Development Summit
23/11/2021 12:30 Q3 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD		Released
Forecast
Spread 		1,74
1,72
1.18%		0,00
0,00
- 		0,00
0,00
-
EBITDA
Million USD		Released
Forecast
Spread 		-7,55
-5,79
-30.42%		-9,06
-10,5
14.03%		-5,60
8,59
-165.15%
EBIT
Million USD		Released
Forecast
Spread 		-7,58
-5,93
-28%		-9,13
-9,81
6.98%		-9,72
-5,80
-67.73%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-9,97
-8,28
-20.42%		-10,5
-10,6
1.1%		4,68
8,50
-44.99%
Net income
Million USD		Released
Forecast
Spread 		-9,50
-8,28
-14.75%		-9,39
-10,6
11.69%		5,09
8,50
-40.07%
EPS
USD		Released
Forecast
Spread 		-0,11
-0,08
-37.5%		-0,03
-0,04
25%		0,01
0,02
-50%
Announcement Date15/04/2115/04/2214/04/23

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-


0,00
0,00
- 		0,07
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		-4,34
-1,90
-128.64%		-0,26
-1,90
86.51%		-0,60
-0,24
-148.1%		-4,53
-0,60
-654.28%


-0,24
-0,30
20.41%		0,01
-0,30
104.83%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,09
-1,90
-167.91%		16,0
-1,90
940.56%		-0,86
-1,24
30.69%		-5,34
-1,60
-234.02%		-0,53


-6,85
-0,40
-1612.5%		0,04
-0,40
110.27%
Net income
Million USD		Released
Forecast
Spread 		-4,85
-1,90
-155.25%		16,0
-1,90
942.74%		-0,78
-1,24
37.26%		-5,29
-1,60
-230.59%		-0,53


-6,85
-0,40
-1612.5%		0,12
-0,40
128.83%
EPS
USD		Released
Forecast
Spread 		-0,01
-0,01
0%		0,04
0,00
- 		0,00
0,00
- 		-0,01
0,00
-


-0,02
0,00
- 		0,00
0,00
-
Announcement Date23/05/2222/08/2218/11/2214/04/2322/05/2318/08/2314/11/23

Upcoming sector events for Mateon Therapeutics, Inc.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Mateon Therapeutics, Inc.

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. OTLC Stock
  4. MATN Stock
  5. Calendar Mateon Therapeutics, Inc.